Gilead Sciences Should Not See Any Impact From HIV-Related Cost Reductions at US Health Dept, Truist Says

 Gilead Sciences should not see any impact from the reported cost reductions at the US Department of Health and Human Services, Truist said in a note 

https://www.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Should-Not-See-Any-Impact-From-HIV-Related-Cost-Reductions-at-US-Healthcare-Departme-49377175/